INOVIO PHARMACEUTICALS, INC. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 16, 2011

Attached files

file filename
10-K - FORM 10-K - INOVIO PHARMACEUTICALS, INC.d10k.htm
EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. - INOVIO PHARMACEUTICALS, INC.dex321.htm
EX-31.2 - CERTIFICATION OF THE CFO - INOVIO PHARMACEUTICALS, INC.dex312.htm
EX-10.5 - EMPLOYMENT AGREEMENT - INOVIO PHARMACEUTICALS, INC.dex105.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - INOVIO PHARMACEUTICALS, INC.dex211.htm
EX-31.1 - CERTIFICATION OF THE CEO - INOVIO PHARMACEUTICALS, INC.dex311.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statements (Form S-3 Nos. 333-76738, 333-108752, 333-111287, 333-116696, 333-118187, 333-123619, 333-131332, 333-134084, 333-140119, 333-160123 and 333-160126; Form S-8 Nos. 333-58168, 333-100077, 333-120061, 333-136126, 333-142938, 333-150769, 333-156035, 333-161559 and 333-166906) of Inovio Pharmaceuticals, Inc. and in the related Prospectuses, of our reports dated March 16, 2011, with respect to the consolidated financial statements of Inovio Pharmaceuticals, Inc., and the effectiveness of internal control over financial reporting of Inovio Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2010.

/s/ Ernst & Young LLP

San Diego, California

March 16, 2011

INOVIO PHARMACEUTICALS, INC. Reports